Skip to main content
OpenTrials
Completed

NCT Number: NCT03963804

Objective Brain Function Assessment of mTBI/Concussion

This study (Part 3) is designed to build a database including EEG, neurocognitive performance, clinical symptoms, history and other relevant data, which will be used to derive a multimodal EEG based algorithm for the identification of concussion and tracking of recovery.

Completed

Looking for future studies?

Notify Me

Key information

Age range

13 year–25 year

Sex eligibility

All sexes

Study type

Observational

Primary location

University of Arkansas, Fayetteville, Arkansas, United States

Loading trial locations.

About this study

Injured/concussed subjects will be studied at time of injury, and at 3 follow-up time points following injury. Subjects will come from the sports and other populations of concussed individuals. They will be matched with controls i.e. not head injured subjects who will also undergo the same set of tests and the same time intervals as the injured subjects. An additional pool of uninjured (not head injured) subjects will be collected who will be assessed at a single time point. This data will be used to populate a database for the purpose of deriving a multimodal concussion index.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

For Injured subjects:

  • Having sustained a traumatic closed head injury within 72 hours (3 days) from time of injury at time of BrainScope assessment;
  • GCS 13-15 at time of BrainScope assessment;
  • No hospital admission due to either head injury or collateral injuries for >24 hours.

For Matched Controls:

  • GCS 15 at time of BrainScope assessment;
  • No prior history of concussion or TBI in the last year.

Exclusion criteria

  • Previously enrolled in the BrainScope CAS Studies;
  • Current CNS active prescription medications taken daily, with the exception of medications being taken for the treatment of Attention Deficit Disorder (ADD) or Attention Deficit Hyperactivity Disorder (ADHD);
  • Forehead, scalp or skull abnormalities that prevents headset application or EEG data collection;
  • History of brain surgery or neurological disease;
  • Pregnant women;
  • Subjects who do not speak English (non-English speaking parents are allowed to consent so long as translation of the consent form in their native language is available);
  • Acute intoxication;
  • Evidence of illicit drug usage;

For Injured subjects:

  • Loss of consciousness ≥ 20 minutes related to the concussion injury;
  • Active fever defined as greater than 100ºF or 37.78ºC at time of BrainScope assessment;
  • Evidence of abnormality visible on Computerized Tomography (CT) of the head related to the traumatic event (Note: neuroimaging is not required for enrollment).

For Matched Controls:

  • Any focal neurological signs including aphasia, apraxia, diplopia, facial droop, dysarthria/slurred speech;
  • History of Motor Vehicle Accident (MVA) requiring an Emergency Department visit within the past 1 year.

Treatment and study plan

BrainScope Ahead 300iP

Device

The BrainScope Battery evaluation will consist of 4 tests to aid in the assessment of concussion: History, Physical, signs and symptoms (SAC, SCAT5), Electrophysiological Function; Neurocognitive Performance Assessment and Ocular Motor Assessment. BrainScope Ahead 300iP will be used to perform EEG and Cognitive assessments.

Primary outcomes

  1. Derivation of algorithm for Likelihood of being concussed using multimodal inputs

    Time frame: 6 months for data acquisition, with each patient studied from time of injury to 45 days after RTP

    Create a database of all assessments including brain electrical activity (EEG features including all frequency bands and measures (power, connectivity,complexity), neurocognitive performance tests scores (throughput measures), balance, and clinical/symptom assessments (SCAT5), to support derivation of a multimodal brain function/concussion index. (NOTE: All EEG and Neurocognitive features are expressed as z-scores relative to age expected normal values to enable combination)

Sponsors and collaborators

Lead sponsor

BrainScope Company, Inc.

Industry

Registry information

Official study title

Objective Brain Function Assessment of mTBI From Initial Injury to Rehabilitation in Concussion

Acronym: CAS13-25

Important dates

Study start
2018
Primary completion
2019
Study completion
2019
First posted
May 28, 2019
Registry last updated
May 28, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.